VYNE Therapeutics (VYNE) FCF Margin Growth (1y) (2018 - 2026)
VYNE Therapeutics (VYNE) FCF Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,187.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - | 98,515.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98,515.00 |
| Jun 30, 2025 | -655,516.00 |
| Mar 31, 2025 | 225,050.00 |
| Dec 31, 2024 | -408,296.00 |
| Sep 30, 2024 | -251,376.00 |
| Jun 30, 2024 | 529,016.00 |
| Mar 31, 2024 | -250,300.00 |
| Dec 31, 2023 | 983,044.00 |
| Sep 30, 2023 | -25,283.00 |
| Jun 30, 2023 | -304,622.00 |
| Mar 31, 2023 | -39,991.00 |
| Dec 31, 2022 | -1.28 Mn |
| Sep 30, 2022 | 866,586.00 |
| Jun 30, 2022 | -117,693.00 |
| Mar 31, 2022 | 20,321.00 |
| Dec 31, 2021 | -321,528.00 |
| Sep 30, 2021 | -1.22 Mn |
| Jun 30, 2021 | -504,344.00 |
| Mar 31, 2021 | -229,542.00 |
| Dec 31, 2020 | 1.66 Mn |